Associated Papers
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
Kizilkaya HS et al.
Nature Metabolism, 2024
38871982 (PubMed )
Supplement: 42255_2024_1061_MOESM4_ESM.xlsx › All_UKBB_samples
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mannino GC et al.
Molecular Diagnosis & Therapy, 2012
Pharmacological characterization of human incretin receptor missense variants.
Fortin JP et al.
The Journal of Pharmacology and Experimental Therapeutics, 2010
Select a paper to view details